What triggered UiPath shares' latest price pullback

Traders Union
All News
Financial News
UiPath slides 2.45% today to $12.15

Highlights

UiPath achieved its first full year of GAAP profitability, posting $282 million in net income on $1.61 billion annual revenue.
The company executed a $1 billion share buyback, initiated a new $500 million program, and expanded high-profile partnerships with Deloitte and Microsoft.
Technicals indicate fading short-term momentum with path likely to trade sideways between $11.41 support and $12.86 resistance, while downside risk persists.

Profitability milestone and deal expansion fail to lift stock sentiment

UiPath reported strong fourth-quarter and full-year fiscal 2026 results, achieving $481 million in Q4 revenue and $1.61 billion in annual revenue, marking its first full year of GAAP profitability with net income of $282 million. The company executed a $1 billion share buyback and authorized a new $500 million repurchase program. UiPath also expanded its partnership with Deloitte through the launch of the Agentic ERP solution and announced a new integration with Microsoft aimed at automating enterprise security operations, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, notes that PATH’s short-term momentum remains fragile despite a brief rally above the SMA-20. He sees the strong quarterly results and buyback as insufficient to offset medium-term technical weakness and continued seller dominance. The negative MACD and overbought oscillators further highlight the risk of a continued downturn, especially if support at $11.41 gives way. Kharitonov points out that recent newsflow has failed to shift sentiment, and longer-term averages cap any sustainable upside. He concludes, "Until the price recovers decisively above $12.86, I see little reason to expect a lasting reversal in trend."

Viktoras Karapetjanc, expert at Traders Union, views PATH’s full-year GAAP profitability and growing partnerships as strong positives for long-term investors. The ongoing collaboration with Microsoft and Deloitte signals robust demand and enterprise adoption. He maintains confidence that PATH’s fundamentals remain attractive, with the buyback providing additional shareholder value even as short-term price action lags. Karapetjanc asserts, "The bullish structure remains intact and I expect further growth as operational momentum builds around automation solutions."

Jainam Mehta, market strategist, observes that divergence among technical indicators signals a potential tactical opportunity. Mehta highlights that oscillators in overbought territory could set up a mean-reversion move if price breaks below $11.41. The sideways drift between $11.41 and $12.86 creates a clear low-risk trading band for short-term traders. He suggests, "A contrarian entry could be considered if intraday selling exhausts near dynamic support, but position-sizing should remain defensive until momentum confirms direction."

Diverging technical momentum as intraday selling meets recent buying

Momentum on the daily timeframe is softening: MACD shows a strong sell while ADX signals weak trend strength. Oscillators present mixed signals — RSI is neutral-bullish but both Stoch RSI and CCI are in overbought territory. BBP indicates buyers have dominated recently, though sellers are exerting pressure today. AO does not reinforce the current trend. Following a higher open ($12.61 vs prior close $12.45), PATH is down 2.45% on the session, trading near the session low of $12.18, with moderate volatility and continued post-open selling pressure. Taken together, momentum and oscillators show divergence, with fading upward momentum not fully confirmed by intraday sellers.

Earlier, analysts noted that UiPath exhibited short-term bullish momentum but warned of persistent volatility and downside risks as technical signals diverged. With the latest price action revealing fading upward momentum amid mixed oscillators and renewed selling pressure, traders should now closely monitor the $11.41 support level for signs of further weakness.

Source of Data: PATH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.